Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
Private Wealth Daily
other

Breye Therapeutics ApS

In network coverage since October 8, 2026 · 2 stories
2Deals on our tracker
Deal recordFull tracker →
Oct 7, 26Deal announcedLjungström family office · Novo Holdings · Mission BioCapital — coverage
Oct 7, 26Deal announcedLjungström family office · Novo Holdings · Mission BioCapital — coverage
Network coverage
Direct & Co-Investments

Ljungström family office co-led AnaCardio AB's €62.5 million Series B, joined Breye Series A

The AnaCardio financing is earmarked to fund a Phase 2b trial of AC01 in about 400 patients across twelve countries.
Direct & Co-Investments · Oct 8Ljungström family office co-led AnaCardio's €62.5m Series B with Novo Holdings
Private Wealth DailyThe morning edition

The private wealth industry in four minutes, every morning at 6:30 a.m. ET. Free.

Free. Every morning. Unsubscribe from any edition in one click.